These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Clinical study of sustained release cephalexin (S-6435 and S-6436) in tonsillitis and pharyngitis (author's transl)]. Kubo N Jpn J Antibiot; 1977 Nov; 30(11):906-10. PubMed ID: 592492 [TBL] [Abstract][Full Text] [Related]
8. [Clinical experience with sustained release cefalexin (S-6436) in surgery (author's transl)]. Takenaka M; Tanimura H; Kamata T; Setoyama M Jpn J Antibiot; 1977 Nov; 30(11):893-7. PubMed ID: 592490 [TBL] [Abstract][Full Text] [Related]
9. [Clinical experience with sustained release cefalexin (S-6437) for pediatric use in pediatrics (author's transl)]. Hayashi M; Sugita K; Murata R; Fujii K Jpn J Antibiot; 1977 Nov; 30(11):881-7. PubMed ID: 592488 [TBL] [Abstract][Full Text] [Related]
10. [Clinical experience with S-6436 in patients with urinary tract infections (author's transl)]. Urata H; Komeda K; Tochigi H; Morishita F; Horiuchi E Jpn J Antibiot; 1977 Oct; 30(10):829-34. PubMed ID: 338939 [TBL] [Abstract][Full Text] [Related]
11. [Study of S-6437 in pediatrics regarding clinical efficacy, blood levels and urinary excretion (author's transl)]. Nanri S; Sunagawa K; Hara N; Kimura K; Osano M Jpn J Antibiot; 1977 Sep; 30(9):699-709. PubMed ID: 916191 [TBL] [Abstract][Full Text] [Related]
12. [Clinical and laboratory studies on S-6437 (a new longacting granule of cephalexin) in pediatric field (author's transl)]. Kondo K; Kuno K; Koide T; Fukaya K; Jose H Jpn J Antibiot; 1977 Sep; 30(9):691-8. PubMed ID: 916190 [TBL] [Abstract][Full Text] [Related]
13. [Clinical experience with sustained release cephalexin (S-6437) in pediatrics (author's transl)]. Hori M; Okamoto K; Kohno S Jpn J Antibiot; 1978 Feb; 31(2):59-71. PubMed ID: 642208 [TBL] [Abstract][Full Text] [Related]
14. [Comparative studies of the efficacy, safety and usefulness of S6472, cefaclor and cephalexin on complicated urinary tract infection by the double-blind method]. Kamidono S; Arakawa S; Fujii A; Kataoka N; Umezu K; Ishigami J; Hirooka K; Shimatani N; Matsushita M; Hikosaka K Jpn J Antibiot; 1985 Oct; 38(10):2735-69. PubMed ID: 3908727 [TBL] [Abstract][Full Text] [Related]
15. [Studies of sustained release cephalexin (S-6437) in pediatrics (author's transl)]. Saito K; Ubukata K; Konno M Jpn J Antibiot; 1977 Sep; 30(9):672-6. PubMed ID: 916187 [TBL] [Abstract][Full Text] [Related]
16. [Clinical and pharmacological evaluation of S-6436 (long acting preparation of cephalexin) in urinary tract infections (author's transl)]. Takamoto H; Kamata H; Hirano M; Niijima T; Onoda T Kansenshogaku Zasshi; 1977 Jun; 51(6):343-52. PubMed ID: 411848 [No Abstract] [Full Text] [Related]